Literature DB >> 8398341

Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.

E Veszelovszky1, L L Thomsen, Z Li, B C Baguley.   

Abstract

Antitumour agents such as flavone acetic acid, xanthenone acetic acid (XAA), 5,6-dimethylxanthenone-4-acetic acid and tumour necrosis factor-alpha, following single dose administration to mice with colon 38 adenocarcinomas, induce tumour haemorrhagic necrosis and an elevation in plasma nitrate. The relationship between these two effects has been studied using firstly a series of methyl-substituted XAA derivatives with varying antitumour activity, and secondly the inhibitors NG-monomethyl-L-arginine (NMMA), N-nitro-L-arginine (NNA) and canavanine, which affect nitric oxide synthesis. Elevation of plasma nitrate resulting from the oxidation of L-arginine by nitric oxide synthase is inhibited by NNA rather than by NMMA or canavanine. The results demonstrate that tumour necrosis can be induced in the absence of a significant elevation of plasma nitrate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398341     DOI: 10.1016/0959-8049(93)90396-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.

Authors:  D J Chaplin; G R Pettit; C S Parkins; S A Hill
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.

Authors:  B C Baguley; G Cole; L L Thomsen; Z Li
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  E Moilanen; L L Thomsen; D W Miles; D W Happerfield; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Authors:  S M Tijono; K Guo; K Henare; B D Palmer; L-C S Wang; S M Albelda; L-M Ching
Journal:  Br J Cancer       Date:  2013-03-12       Impact factor: 7.640

5.  Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.

Authors:  S A Butler; P J Wood; S Cole; C Williams; G E Adams; I J Stratford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.

Authors:  A L Laws; A M Matthew; J A Double; M C Bibby
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.